Medical - Devices
Compare Stocks
4 / 10Stock Comparison
SINT vs AHCO vs MDT vs HOLX
Revenue, margins, valuation, and 5-year total return — side by side.
Medical - Devices
Medical - Devices
Medical - Instruments & Supplies
SINT vs AHCO vs MDT vs HOLX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Medical - Devices | Medical - Devices | Medical - Devices | Medical - Instruments & Supplies |
| Market Cap | $9M | $1.54B | $97.62B | $16.97B |
| Revenue (TTM) | $1M | $2.86B | $35.48B | $4.13B |
| Net Income (TTM) | $-17M | $-80M | $4.61B | $544M |
| Gross Margin | 50.0% | 1.8% | 61.9% | 52.8% |
| Operating Margin | -8.3% | 7.2% | 17.9% | 17.5% |
| Forward P/E | — | 12.6x | 13.8x | 17.2x |
| Total Debt | $3M | $1.90B | $28.52B | $2.63B |
| Cash & Equiv. | $4M | $106M | $2.22B | $1.96B |
SINT vs AHCO vs MDT vs HOLX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sintx Technologies,… (SINT) | 100 | 0.0 | -100.0% |
| AdaptHealth Corp. (AHCO) | 100 | 69.8 | -30.2% |
| Medtronic plc (MDT) | 100 | 77.2 | -22.8% |
| Hologic, Inc. (HOLX) | 100 | 142.6 | +42.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SINT vs AHCO vs MDT vs HOLX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SINT lags the leaders in this set but could rank higher in a more targeted comparison.
AHCO is the clearest fit if your priority is value.
- Lower P/E (12.6x vs 17.2x)
MDT carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 36 yrs, beta 0.42, yield 3.7%
- Rev growth 3.6%, EPS growth 30.8%, 3Y rev CAGR 1.9%
- Lower volatility, beta 0.42, Low D/E 59.1%, current ratio 1.85x
- Beta 0.42, yield 3.7%, current ratio 1.85x
HOLX is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 124.3% 10Y total return vs MDT's 24.3%
- 13.2% margin vs SINT's -13.6%
- +35.3% vs MDT's -5.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.6% revenue growth vs SINT's -18.3% | |
| Value | Lower P/E (12.6x vs 17.2x) | |
| Quality / Margins | 13.2% margin vs SINT's -13.6% | |
| Stability / Safety | Beta 0.42 vs SINT's 1.94, lower leverage | |
| Dividends | 3.7% yield; 36-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +35.3% vs MDT's -5.5% | |
| Efficiency (ROA) | 175.8% ROA vs SINT's -159.9%, ROIC 6.0% vs -253.2% |
SINT vs AHCO vs MDT vs HOLX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SINT vs AHCO vs MDT vs HOLX — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
HOLX leads in 2 of 6 categories
AHCO leads 1 • MDT leads 1 • SINT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — MDT and HOLX each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MDT is the larger business by revenue, generating $35.5B annually — 29109.1x SINT's $1M. HOLX is the more profitable business, keeping 13.2% of every revenue dollar as net income compared to SINT's -13.6%. On growth, AHCO holds the edge at +41.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $1M | $2.9B | $35.5B | $4.1B |
| EBITDAEarnings before interest/tax | -$9M | $504M | $9.4B | $974M |
| Net IncomeAfter-tax profit | -$17M | -$80M | $4.6B | $544M |
| Free Cash FlowCash after capex | -$8M | $219M | $5.4B | $1000M |
| Gross MarginGross profit ÷ Revenue | +50.0% | +1.8% | +61.9% | +52.8% |
| Operating MarginEBIT ÷ Revenue | -8.3% | +7.2% | +17.9% | +17.5% |
| Net MarginNet income ÷ Revenue | -13.6% | -2.8% | +13.0% | +13.2% |
| FCF MarginFCF ÷ Revenue | -6.3% | +7.7% | +15.2% | +24.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -43.3% | +41.2% | +8.8% | +2.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +50.2% | -140.0% | -11.9% | -9.2% |
Valuation Metrics
AHCO leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 21.1x trailing earnings, MDT trades at a 31% valuation discount to HOLX's 30.5x P/E. On an enterprise value basis, AHCO's 5.6x EV/EBITDA is more attractive than HOLX's 17.4x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $9M | $1.5B | $97.6B | $17.0B |
| Enterprise ValueMkt cap + debt − cash | $8M | $3.3B | $123.9B | $17.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.39x | -21.73x | 21.09x | 30.53x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 12.61x | 13.80x | 17.21x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 35.17x | — |
| EV / EBITDAEnterprise value multiple | — | 5.56x | 14.06x | 17.39x |
| Price / SalesMarket cap ÷ Revenue | 8.52x | 0.47x | 2.91x | 4.14x |
| Price / BookPrice ÷ Book value/share | 2.27x | 1.00x | 2.04x | 3.43x |
| Price / FCFMarket cap ÷ FCF | — | 7.00x | 18.83x | 18.44x |
Profitability & Efficiency
HOLX leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
HOLX delivers a 11.0% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-4 for SINT. HOLX carries lower financial leverage with a 0.52x debt-to-equity ratio, signaling a more conservative balance sheet compared to AHCO's 1.25x. On the Piotroski fundamental quality scale (0–9), HOLX scores 7/9 vs SINT's 3/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -3.7% | -5.1% | +9.4% | +11.0% |
| ROA (TTM)Return on assets | -159.9% | -1.8% | +175.8% | +6.1% |
| ROICReturn on invested capital | -2.5% | +4.0% | +6.0% | +9.4% |
| ROCEReturn on capital employed | -162.4% | +5.0% | +7.5% | +8.8% |
| Piotroski ScoreFundamental quality 0–9 | 3 | 5 | 6 | 7 |
| Debt / EquityFinancial leverage | 1.11x | 1.25x | 0.59x | 0.52x |
| Net DebtTotal debt minus cash | -$898,000 | $1.8B | $26.3B | $667M |
| Cash & Equiv.Liquid assets | $4M | $106M | $2.2B | $2.0B |
| Total DebtShort + long-term debt | $3M | $1.9B | $28.5B | $2.6B |
| Interest CoverageEBIT ÷ Interest expense | -181.30x | 0.65x | 9.08x | 8.00x |
Total Returns (Dividends Reinvested)
HOLX leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HOLX five years ago would be worth $11,678 today (with dividends reinvested), compared to $1 for SINT. Over the past 12 months, HOLX leads with a +35.3% total return vs MDT's -5.5%. The 3-year compound annual growth rate (CAGR) favors MDT at -2.1% vs SINT's -79.9% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -36.5% | +16.9% | -20.0% | +1.9% |
| 1-Year ReturnPast 12 months | -5.1% | +34.8% | -5.5% | +35.3% |
| 3-Year ReturnCumulative with dividends | -99.2% | -6.4% | -6.3% | -8.5% |
| 5-Year ReturnCumulative with dividends | -100.0% | -54.7% | -29.2% | +16.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +16.5% | +24.3% | +124.3% |
| CAGR (3Y)Annualised 3-year return | -79.9% | -2.2% | -2.1% | -2.9% |
Risk & Volatility
Evenly matched — MDT and HOLX each lead in 1 of 2 comparable metrics.
Risk & Volatility
MDT is the less volatile stock with a 0.42 beta — it tends to amplify market swings less than SINT's 1.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HOLX currently trades 100.0% from its 52-week high vs SINT's 35.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.94x | 0.72x | 0.42x | 0.45x |
| 52-Week HighHighest price in past year | $6.78 | $13.43 | $106.33 | $76.04 |
| 52-Week LowLowest price in past year | $1.99 | $8.06 | $75.91 | $53.62 |
| % of 52W HighCurrent price vs 52-week peak | +35.4% | +84.1% | +71.6% | +100.0% |
| RSI (14)Momentum oscillator 0–100 | 45.7 | 43.4 | 29.2 | 69.1 |
| Avg Volume (50D)Average daily shares traded | 37K | 1.4M | 7.9M | 10.3M |
Analyst Outlook
MDT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AHCO as "Buy", MDT as "Buy", HOLX as "Hold". Consensus price targets imply 43.8% upside for MDT (target: $110) vs 3.9% for HOLX (target: $79). MDT is the only dividend payer here at 3.65% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $14.00 | $109.50 | $79.00 |
| # AnalystsCovering analysts | — | 12 | 49 | 42 |
| Dividend YieldAnnual dividend ÷ price | — | — | +3.7% | — |
| Dividend StreakConsecutive years of raises | 1 | 1 | 36 | — |
| Dividend / ShareAnnual DPS | — | — | $2.78 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.5% | 0.0% | +3.3% | +4.4% |
HOLX leads in 2 of 6 categories (Profitability & Efficiency, Total Returns). AHCO leads in 1 (Valuation Metrics). 2 tied.
SINT vs AHCO vs MDT vs HOLX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SINT or AHCO or MDT or HOLX a better buy right now?
For growth investors, Medtronic plc (MDT) is the stronger pick with 3.
6% revenue growth year-over-year, versus -18. 3% for Sintx Technologies, Inc. (SINT). Medtronic plc (MDT) offers the better valuation at 21. 1x trailing P/E (13. 8x forward), making it the more compelling value choice. Analysts rate AdaptHealth Corp. (AHCO) a "Buy" — based on 12 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SINT or AHCO or MDT or HOLX?
On trailing P/E, Medtronic plc (MDT) is the cheapest at 21.
1x versus Hologic, Inc. at 30. 5x. On forward P/E, AdaptHealth Corp. is actually cheaper at 12. 6x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — SINT or AHCO or MDT or HOLX?
Over the past 5 years, Hologic, Inc.
(HOLX) delivered a total return of +16. 8%, compared to -100. 0% for Sintx Technologies, Inc. (SINT). Over 10 years, the gap is even starker: HOLX returned +124. 3% versus SINT's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SINT or AHCO or MDT or HOLX?
By beta (market sensitivity over 5 years), Medtronic plc (MDT) is the lower-risk stock at 0.
42β versus Sintx Technologies, Inc. 's 1. 94β — meaning SINT is approximately 357% more volatile than MDT relative to the S&P 500. On balance sheet safety, Hologic, Inc. (HOLX) carries a lower debt/equity ratio of 52% versus 125% for AdaptHealth Corp. — giving it more financial flexibility in a downturn.
05Which is growing faster — SINT or AHCO or MDT or HOLX?
By revenue growth (latest reported year), Medtronic plc (MDT) is pulling ahead at 3.
6% versus -18. 3% for Sintx Technologies, Inc. (SINT). On earnings-per-share growth, the picture is similar: Sintx Technologies, Inc. grew EPS 59. 4% year-over-year, compared to -185. 2% for AdaptHealth Corp.. Over a 3-year CAGR, SINT leads at 19. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SINT or AHCO or MDT or HOLX?
Medtronic plc (MDT) is the more profitable company, earning 13.
9% net margin versus -1678. 1% for Sintx Technologies, Inc. — meaning it keeps 13. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MDT leads at 17. 8% versus -1053. 1% for SINT. At the gross margin level — before operating expenses — MDT leads at 65. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SINT or AHCO or MDT or HOLX more undervalued right now?
On forward earnings alone, AdaptHealth Corp.
(AHCO) trades at 12. 6x forward P/E versus 17. 2x for Hologic, Inc. — 4. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MDT: 43. 8% to $109. 50.
08Which pays a better dividend — SINT or AHCO or MDT or HOLX?
In this comparison, MDT (3.
7% yield) pays a dividend. SINT, AHCO, HOLX do not pay a meaningful dividend and should not be held primarily for income.
09Is SINT or AHCO or MDT or HOLX better for a retirement portfolio?
For long-horizon retirement investors, Medtronic plc (MDT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
42), 3. 7% yield). Sintx Technologies, Inc. (SINT) carries a higher beta of 1. 94 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MDT: +24. 3%, SINT: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SINT and AHCO and MDT and HOLX?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SINT is a small-cap quality compounder stock; AHCO is a small-cap quality compounder stock; MDT is a mid-cap income-oriented stock; HOLX is a mid-cap quality compounder stock. MDT pays a dividend while SINT, AHCO, HOLX do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.